Skip to main content

Knowledge Management and Process Monitoring of Pharmaceutical Processes in the Quality by Design Paradigm

  • Chapter
  • First Online:
Measurement, Monitoring, Modelling and Control of Bioprocesses

Part of the book series: Advances in Biochemical Engineering/Biotechnology ((ABE,volume 132))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BDS:

Bulk Drug Substance

BPR:

Batch production record

CAPA:

Corrective And Preventive Action

cGMP:

Current good manufacturing practices

CFR:

Code of Federal Regulations

CPP:

Critical process parameters

CQA:

Critical quality attributes

DO:

Dissolved oxygen

ERP:

Enterprise resource planning

FDA:

Food and Drug Administration

HCD:

Host cell DNA

ICH:

International Conference on Harmonisation

LIMS:

Laboratory information management system

OOS:

Out of specification

PAT:

Process analytical technology

PCA:

Principal component analysis

PLS:

Partial least squares

PQ:

Process qualification

QMS:

Quality management system

QbD:

Quality by design

RVLP:

Retrovirus Like Particles

SOP:

Standard operating procedure

SPE:

Squared prediction error

SCADA:

Supervisory control and data acquisition

TPP:

Target Product Profile

References

  1. Awad EM, Ghaziri HM (2007) Understanding knowledge. Knowledge management, 1st edn. Pearson Education, India, pp 60–65

    Google Scholar 

  2. Bansal A, Hans J, Rathore AS (2011) Operation excellence: more data or smarter approach? BioPharm Int 24(6):36–41

    Google Scholar 

  3. Cinar A, Parulekar SJ, Undey C, Birol G (2003) Batch fermentation: modeling, monitoring and control. CRC, New York

    Google Scholar 

  4. Gunther JC, Conner JS, Seborg DE (2009) Process monitoring and quality variable prediction utilizing PLS in industrial fed-batch cell culture. J Process Control 19:914–921

    Article  CAS  Google Scholar 

  5. Guidance for Industry, Process Validation: General Principles and Practices (2011) US Department of Health and Human Services, Food and Drug Administration, Revision 1

    Google Scholar 

  6. Hans J, Bansal A (2009) Biopharmaceutical information infrastructure 2.0. BioProcess Int 7(11):10–19

    Google Scholar 

  7. ICH Harmonised Tripartite Guideline: Q8(R1) Pharmaceutical Development (2008) http://www.ich.org/LOB/media/MEDIA4986.pdf

  8. ICH Harmonised Tripartite Guideline: Q9 Quality Risk Management (2005) http://www.ich.org/LOB/media/MEDIA1957.pdf

  9. ICH Harmonised Tripartite Guideline: Q10 Pharmaceutical Quality System (2008) http://www.ich.org/LOB/media/MEDIA3917.pdf

  10. Kirdar AO, Connor JS, Baclaski J, Rathore AS (2007) Application of multivariate analysis toward biotech processes: case study of a cell-culture unit operation. Biotechnol Prog 23:61–67

    Article  CAS  Google Scholar 

  11. Konold P, Woolfenden R II, Undey C, Rathore AS (2009) Monitoring of biopharmaceutical processes: present and future approaches. BioPharm Int 22(5):26–39

    Google Scholar 

  12. Kozlowski S, Swann P (2009) Considerations for biotechnology product quality by design. In: Rathore AS, Mhatre R (ed) Quality by design for biopharmaceuticals: perspectives and case studies. Wiley, New Jersey, pp 9–30

    Google Scholar 

  13. Martin EB, Morris AJ (2002) Enhanced bio-manufacturing through advanced multivariate statistical technologies. J Biotechnol 99:223–235

    Article  CAS  Google Scholar 

  14. Nucci ER, Cruz AJG, Giordano RC (2010) Monitoring bioreactors using principal component analysis: production of penicillin G acylase as a case study. Bioprocess Biosyst Eng 33:557–564. doi:10.1007/s00449-009-0377-y

    Article  CAS  Google Scholar 

  15. PAT Guidance for Industry—A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance (2004) US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA)

    Google Scholar 

  16. Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals (2008) Code of Federal Regulations, Title 21, vol 4, US Department of Health and Human Service, Food and Drug Administration (FDA)

    Google Scholar 

  17. Rathore AS (2009) A roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol 27:546–553

    Article  CAS  Google Scholar 

  18. Rathore AS, Winkle H (2009) Quality by design for pharmaceuticals: regulatory perspective and approach. Nat Biotechnol 27:26–34

    Article  CAS  Google Scholar 

  19. Rathore AS, Parr L, Dermawan S, Lawson K, Lu Y (2010) Large scale demonstration of process analytical technology (PAT) in bioprocessing: use of high performance liquid chromatography (HPLC) for making real time pooling decisions for process chromatography. Biotechnol Prog 26:448–457

    CAS  Google Scholar 

  20. Undey C, Tatara E, Cinar A (2003) Real-time batch process supervision by integrated knowledge-based systems and multivariate statistical methods. Eng Appl Artif Intell 16:555–566

    Article  Google Scholar 

  21. Undey C, Ertunc S, Cinar A (2003) Online batch/fed-batch process performance monitoring, quality prediction and variable contributions analysis for diagnosis. Ind Eng Chem Res 42(20):4645–4658

    Article  Google Scholar 

  22. Undey C, Tatara E, Cinar A (2004) Intelligent real-time performance monitoring and quality prediction for batch/fed-batch cultivations. J Biotechnol 108(1):61–77

    Article  CAS  Google Scholar 

  23. Ündey C, Ertunc S, Mistretta T, Looze B (2010) Applied advanced process analytics in biopharmaceutical manufacturing: Challenges and prospects in real-time monitoring and control. J Process Control 20:1009–1018

    Article  Google Scholar 

  24. Yoo CK, Lee IB (2006) Nonlinear multivariate filtering and bioprocess monitoring for supervising nonlinear biological processes. Process Biochem 41:1854–1863

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anurag S. Rathore .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rathore, A.S., Bansal, A., Hans, J. (2012). Knowledge Management and Process Monitoring of Pharmaceutical Processes in the Quality by Design Paradigm. In: Mandenius, CF., Titchener-Hooker, N. (eds) Measurement, Monitoring, Modelling and Control of Bioprocesses. Advances in Biochemical Engineering/Biotechnology, vol 132. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2012_172

Download citation

Publish with us

Policies and ethics